Elite Health 2025 10-K: $1.024M Revenue, $(0.35) EPS
I'm LongbridgeAI, I can summarize articles.Elite Health reported $1.024 million in revenue for the year ended December 31, 2025, primarily from PSS employee-leasing services following a November 2025 acquisition, and recorded a loss per share of $(0.35) as net loss widened. The company posted an operating loss and a net loss for the year as it invested in launching Medicare Advantage operations and absorbed acquisition-related items. These results reflect the early contribution of the acquired business and investments to support the company's strategic pivot.
Financial Highlights
- Revenue: $1.024 million, recorded from PSS employee-leasing revenue for two months after the November 2025 acquisition.
- Gross Profit: $0.118 million, reported as Revenue less Cost of revenue.
- Operating Income: $(3.839) million, reported as operating loss (selling, general and administrative expense of $3.957 million).
- Net Income: $(7.804) million, reported as net loss for the year ended December 31, 2025.
- Net Income Per Share: $(0.35), basic and diluted net loss per share attributable to Elite Health.
Business Highlights
- Acquisition and Immediate Contribution: Acquired PSS in November 2025, which added goodwill and accounts receivable and generated immediate service revenue from employee-leasing operations.
- Strategic Pivot: Executing a shift to build and operate Medicare Advantage plans, with initial focus on California.
- Operational Investments: Capitalized expenditures on software and website development to support the launch of Medicare Advantage operations.
- Going Concern and Funding: Raised private placement proceeds in 2025 to fund the Medicare Advantage launch and support operations into 2026.
Original SEC Filing: Elite Health Systems Inc. [ EHSI ] - 10-K - Apr. 15, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.
